Connecting Family Voices to Clinical Trial Readiness (IMAGE)

CURE SYNGAP1

Connecting Family Voices to Clinical Trial Readiness

Caption

CURE SYNGAP1’s investment in RARE-X strengthens ProMMiS by helping collect secure, high-quality patient-reported outcome data from families, turning lived experience into meaningful measures for future clinical trials.

Credit

CURE SYNGAP1

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.